Printer Friendly
The Free Library
19,595,260 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cholestech L.D.X System Chosen for Parke-Davis' 1999 Disease Management Initiative at CVS Drug Stores.


HAYWARD, Calif.--(BW HealthWire)--Aug. 17, 1999--

Cholestech Corporation (Nasdaq:CTEC CTEC Course and Teacher Evaluation Council (Northwestern University, Office of the Register)
CTEC Certified Technical Education Center
CTEC Certified Technical Education Center (Microsoft) 
) announced today that the Cholestech L.D.X(R) System has been selected by Parke-Davis, a division of Warner-Lambert Company, and Pfizer as part of a nationwide cholesterol screening and education initiative.

Preventive care Preventive care is a set of measures taken in advance of symptoms to prevent illness or injury. This type of care is best exemplified by routine physical examinations and immunizations. The emphasis is on preventing illnesses before they occur. See also
  • Public health
 testing for ongoing lipid management of hyperlipidemia hyperlipidemia /hy·per·lip·id·emia/ (-lip?i-de´me-ah) elevated concentrations of any or all of the lipids in the plasma, including hypertriglyceridemia, hypercholesterolemia, etc.  is now available at select retail CVS (1) (Concurrent Versions System) A version control system for Unix that was initially developed as a series of shell scripts in the mid-1980s. CVS maintains the changes between one source code version and another and stores all the changes in one file.  pharmacies as part of a pilot program in pharmacy based intervention and disease management.

"We are excited by this opportunity to partner with Parke-Davis, Pfizer and Cholestech, as we expand our Pharmacy Care Services," said Chris Bodine, senior vice president of Health Care Services of CVS. "CVS is committed to providing programs of patient care and effective disease management, which support the needs of our customers."

Parke-Davis, Pfizer has provided an educational grant to support cholesterol screening and education in participating pharmacies, including lipid management education, patient education concerning the risks of hyperlipidemia, and pharmacist support programs to test and counsel patients.

"We began our pilot program with CVS and Parke-Davis in January to assist the public in determining their potential risk of coronary heart disease coronary heart disease: see coronary artery disease.
coronary heart disease
 or ischemic heart disease

Progressive reduction of blood supply to the heart muscle due to narrowing or blocking of a coronary artery (see atherosclerosis).
, the number one killer of Americans," said Warren E. Pinckert II, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Cholestech.

"Cholestech has been proud to be a part of Parke-Davis' many programs to educate consumers on the risks of high cholesterol Cholesterol, High Definition

Cholesterol is a fatty substance found in animal tissue and is an important component to the human body. It is manufactured in the liver and carried throughout the body in the bloodstream.
 and the steps Americans can take to reach their target lipid levels and control this potentially life-threatening disease. Our pharmacy partner, CVS, has been able to establish a leadership position in pharmacy-based disease management through this pilot and other customer care programs."

The Cholestech L.D.X is a telephone-sized device that can conduct multiple simultaneous diagnostic tests from a single drop of blood and provide results, in less than five minutes, that are as accurate as similar tests performed in clinical and hospital labs. The Cholestech L.D.X System's nearly immediate results enable healthcare professionals to counsel patients during the same visit.

Cholestech Corporation manufactures and markets a proprietary system to healthcare, wellness, and disease management professionals for use in preventative care testing. The Cholestech L.D.X System is positioned to benefit from the increasing emphasis on preventive health care and disease management.

Cholestech's portfolio of CLIA-waived products is designed to offer efficient and economic diagnostic screening and therapeutic monitoring options that will ultimately enable people to lead longer, healthier, and more active lives. For more information about Cholestech, please visit the website at http://www.cholestech.com.

CVS is the largest provider of prescriptions in the nation and is America's No. 1 drugstore chain in terms of store count, leading the Northeast, Mid-Atlantic, Southeast and Midwest regions. For more information about CVS see the CVS website at http://www.CVS.com.

Parke-Davis, a division of Warner-Lambert Company, is devoted to discovering, developing, manufacturing and marketing quality pharmaceutical products. Its central research focus is on heart disease, diabetes, infectious diseases infectious diseases: see communicable diseases. , disorders of the central nervous system and women's healthcare. Warner-Lambert is a worldwide company employing more than 43,000 people and, along with Parke-Davis, is headquartered in Morris Plains, N.J.

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops and markets innovative medicines for humans and animals. Pfizer is headquartered in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
.

For full prescribing information, please call Parke-Davis Medical Affairs at 800/223-0432 or visit their website at http://www.parke-davis.com/Lipitor.htm.

Statements in this press release other than historical fact, are forward looking statements, the accuracy of which is necessarily subject to risks and uncertainties. Actual results may be affected by additional factors set forth in the company's Securities and Exchange Commission filings including the company's Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the year ended March 26, 1999, and Form 10-Q Form 10-Q

See 10-Q.
 for the quarter ended June 25, 1999.

Note to Editors: Cholestech L.D.X(R) System is a registered trademark of Cholestech Corporation.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 18, 1999
Words:645
Previous Article:Rotterdam City Ring Connected to Versatel Broadband Fiber Optic Network.
Next Article:SmartPortfolio.Com Announces Investment Opinion.
Topics:



Related Articles
Medicine for the masses.
Cholestech L.D.X System Chosen for Parke-Davis' 1999 Disease Management Initiative.
Vying for Viagra.
Kaiser Shrugs Off CVS Decision To Reject Prescription Cards.
Rezulin: fast track to failure.
Michael D. Casey of Matrix Pharmaceutical Joins Cholestech Board of Directors.
FDA PANEL RECOMMENDS DIABETES DRUG.
WEAKENED VACCINE PROMPTS INFLUENZA ALERT.
Jury finds Rezulin manufacturer acted with `malice'.
Lawsuits fault off-label use of Neurontin in suicide cases.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles